About
Basic Data Updated:
2 hours agoThe business of contract manufacturing formulations for domestic and multinational pharmaceutical companies is the specialty of Akums Drugs and Pharmaceuticals Limited. With multiple manufacturing facilities situated in Haridwar and Guwahati, the company operates through its wholly-owned subsidiaries Pure & Cure Healthcare Private Limited, Malik Lifesciences Private Limited, and Maxcure Nutravedics Limited. Akums Drugs and Pharmaceuticals Limited is a prominent player in the pharmaceutical industry, offering a wide range of pharmaceutical delivery systems such as tablets, capsules, soft gelatin, dry syrup, liquid orals, injections - dry and liquid, pre-filled syringes, eye and ear drops, hormones, ointments, cosmetics, ayurvedic, herbal, nutraceuticals, and other similar products.
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24239DL2004PLC125888 |
| Company No. | 125888 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 19 Apr 2004 |
| Date of AGM | 30 Jun 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Products or Services related to Akums Drugs And Pharmaceuticals Limited
Eye Drops
Allopathic Ear Drop
Hormone Tablet
Herbal Joint Pain Relief Tablets
Financials of Akums Drugs And Pharmaceuticals Limited
Akums Drugs And Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.84% increase. The company also saw a substantial fall in profitability, with a 162.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 67.28%.
Enhance accessibility to Akums Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Akums Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Akums Drugs And Pharmaceuticals Limited
Unlock and access historical data on people associated with Akums Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
Sumeet Sood
CFOStatus: Current
Dharamvir Malik Company SecretaryStatus: Current
SJ
Sanjeev Jain Managing DirectorAppointment Date: 19-Apr-2004
Status: Current
SJ
Sandeep Jain Managing DirectorAppointment Date: 19-Apr-2004
Status: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sbicap Trustee Company Limited Creation Date: 08 Feb 2023 | ₹305.00 Cr | Open |
Others Creation Date: 03 Feb 2020 | ₹2.25 M | Open |
Yes Bank Limited Creation Date: 15 Jul 2022 | ₹60.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akums Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akums Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
16 years 2 months 
Recent activity within the organization
Charges
A charge registered on 27 Apr 2010 via Charge ID 10217825 with Standard Chartered Bank was fully satisfied on 14 Aug 2023.
14 Aug 2023Charges
A charge registered on 13 Jul 2022 via Charge ID 100601001 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 08 Aug 2023.
08 Aug 2023Charges
A charge registered on 16 Aug 2021 via Charge ID 100494543 with Hdfc Bank Limited was fully satisfied on 05 Aug 2023.
05 Aug 2023Charges
A charge registered on 11 Apr 2022 via Charge ID 100565416 with Citi Bank N.A. was fully satisfied on 02 Aug 2023.
02 Aug 2023Charges
A charge registered on 12 Feb 2021 via Charge ID 100443321 with Citi Bank N.A. was fully satisfied on 02 Aug 2023.
02 Aug 2023
Recent News, Updates & Announcement
Akums introduces Hydroxyurea oral suspension for sickle cell disease.Pharmaceutical Technology 18 Mar 2024
- Akums Drugs files draft IPO papers with Sebi eyes Rs 680 cr via fresh issue.
Moneycontrol 11 Feb 2024
- Akums gets approval for triple combination diabetes treatment.
BioSpectrum India 26 Jul 2023
- Akums Bags Prestigious Business Leadership Award.
BioSpectrum India 10 Aug 2018
- OptiBiotix to bring cholesterol reduction product to India.
FFOODS Spectrum 18 May 2018
Frequently asked questions
What is the Incorporation or founding date of Akums Drugs And Pharmaceuticals Limited?
